As direct evidence for the mechanisms that correlate ACBD3 expression and cancer prognosis are very limited, we have used in silico tools to provide a better insight of ACBD3 expression, regulation, and mutational landscape in healthy and cancerous breast tissue. The gene discussed is ACBD3; the disease is cancer.